A detailed history of Accurate Wealth Management, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Accurate Wealth Management, LLC holds 4,177 shares of BMY stock, worth $240,929. This represents 0.05% of its overall portfolio holdings.

Number of Shares
4,177
Holding current value
$240,929
% of portfolio
0.05%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 17, 2024

BUY
$39.66 - $51.75 $165,659 - $216,159
4,177 New
4,177 $216,000
Q1 2024

Apr 22, 2024

BUY
$47.98 - $54.4 $10,363 - $11,750
216 Added 4.0%
5,612 $304,000
Q4 2023

Jan 12, 2024

SELL
$48.48 - $57.85 $191,932 - $229,028
-3,959 Reduced 42.32%
5,396 $276,000
Q3 2023

Oct 23, 2023

SELL
$57.89 - $64.73 $203,541 - $227,590
-3,516 Reduced 27.32%
9,355 $542,000
Q2 2023

Jul 24, 2023

BUY
$63.71 - $70.74 $213,683 - $237,261
3,354 Added 35.24%
12,871 $823,000
Q1 2023

Apr 13, 2023

BUY
$65.71 - $74.53 $198,247 - $224,857
3,017 Added 46.42%
9,517 $659,000
Q4 2022

Jan 11, 2023

SELL
$68.48 - $81.09 $85,394 - $101,119
-1,247 Reduced 16.1%
6,500 $0
Q3 2022

Nov 14, 2022

BUY
$0.13 - $76.84 $176 - $104,041
1,354 Added 21.18%
7,747 $550,000
Q2 2022

Aug 04, 2022

SELL
$72.62 - $79.98 $1.43 Million - $1.58 Million
-19,742 Reduced 75.54%
6,393 $485,000
Q1 2022

May 10, 2022

BUY
$61.48 - $73.72 $1.06 Million - $1.28 Million
17,311 Added 196.18%
26,135 $1.91 Million
Q4 2021

Feb 08, 2022

BUY
$53.63 - $62.52 $19,199 - $22,382
358 Added 4.23%
8,824 $518,000
Q3 2021

Oct 22, 2021

BUY
$59.17 - $69.31 $103,133 - $120,807
1,743 Added 25.93%
8,466 $490,000
Q2 2021

Aug 25, 2021

BUY
$61.91 - $67.42 $416,220 - $453,264
6,723 New
6,723 $449,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $123B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Accurate Wealth Management, LLC Portfolio

Follow Accurate Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Accurate Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Accurate Wealth Management, LLC with notifications on news.